NCT02650869View on ClinicalTrials.gov

Role of Probiotics for Prevention of NEC in Preterm VLBW Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Necrotizing Enterocolitis
Interventions
DIETARY_SUPPLEMENT

Probiotics

probiotics at a dose of 3x109 CFU/day. (Cap TS6 probiotic + contain Bifidobacterium spp., Lactobacillus at 6x109 CFU = 6 billion CFU manufactured by TENSALL BIO-TECH CO.LTD.Taiwan, distributed by Century Health Care, Bangladesh)

DIETARY_SUPPLEMENT

Breast milk

Normal breast milk will be given as part of standard care

All Listed Sponsors
lead

Sylhet M.A.G.Osmani Medical College

OTHER

NCT02650869 - Role of Probiotics for Prevention of NEC in Preterm VLBW Infants | Biotech Hunter | Biotech Hunter